Factors that facilitate infant survival in a low socio-economic community in Lagos State, Nigeria

Autor: CO Agomo, PU Agomo, D Obomanu, EO Idigbe, Nneoma Idika

Publikováno v: BASE-Bielefeld Academic Search Engine
Nigerian Journal of Health and Biomedical Sciences; Vol 4, No 2 (2005); 125-129

Infants are delicate, relying mostly on caregivers for their survival. Their survival is plagued by diseases, poverty, behavioural habits and cultural beliefs of the caregivers in the developing countries. For strategies to improve infant survival, t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d2d9f3481c2389b81fc86a287afa62b
http://ajol.info/index.php/njhbs/article/view/11553

Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study.

Autor: Onwuamah CK; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, 6 Edmund Crescent, Yaba, Lagos, 101212, Nigeria. chikaonwuamah@yahoo.com., Okpokwu J; Jos University Teaching Hospital, Jos, Plateau State, Nigeria., Audu R; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, 6 Edmund Crescent, Yaba, Lagos, 101212, Nigeria., Imade G; Jos University Teaching Hospital, Jos, Plateau State, Nigeria., Meloni ST; Harvard T. H. Chan School of Public Health, Boston, MA, USA., Okwuraiwe A; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, 6 Edmund Crescent, Yaba, Lagos, 101212, Nigeria., Chebu P; APIN Public Health Initiative Nigeria, Ltd./Gte, Abuja, FCT, Nigeria., Musa AZ; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, 6 Edmund Crescent, Yaba, Lagos, 101212, Nigeria., Chaplin B; Harvard T. H. Chan School of Public Health, Boston, MA, USA., Dalhatu I; Centers for Disease Control-Nigeria, Abuja, FCT, Nigeria., Agbaji O; Jos University Teaching Hospital, Jos, Plateau State, Nigeria., Samuels J; APIN Public Health Initiative Nigeria, Ltd./Gte, Abuja, FCT, Nigeria., Ezechi O; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, 6 Edmund Crescent, Yaba, Lagos, 101212, Nigeria., Ahmed M; Centers for Disease Control-Nigeria, Abuja, FCT, Nigeria., Odaibo G; University of Ibadan, Ibadan, Oyo State, Nigeria., Olaleye DO; University of Ibadan, Ibadan, Oyo State, Nigeria., Okonkwo P; APIN Public Health Initiative Nigeria, Ltd./Gte, Abuja, FCT, Nigeria., Salako BL; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, 6 Edmund Crescent, Yaba, Lagos, 101212, Nigeria., Raizes E; Centers for Disease Control and Prevention, Atlanta, GA, USA., Yang C; Centers for Disease Control and Prevention, Atlanta, GA, USA., Kanki PJ; Harvard T. H. Chan School of Public Health, Boston, MA, USA., Idigbe EO; Microbiology Department, Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, 6 Edmund Crescent, Yaba, Lagos, 101212, Nigeria.

Publikováno v: BMC microbiology [BMC Microbiol] 2020 Jan 20; Vol. 20 (1), pp. 17. Date of Electronic Publication: 2020 Jan 20.

The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance.

Autor: Gehre F; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia.; Institute of Tropical Medicine, Antwerp, Belgium., Otu J; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia., Kendall L; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia., Forson A; University of Ghana Medical School, Accra, Ghana.; Korle-Bu Teaching Hospital, Accra, Ghana., Kwara A; Warren Alpert Medical School of Brown University, Providence, RI, USA.; The Miriam Hospital, Providence, RI, USA., Kudzawu S; Korle-Bu Teaching Hospital, Accra, Ghana., Kehinde AO; College of Medicine, University of Ibadan, Ibadan, Nigeria.; University College Hospital, Ibadan, Oyo, 23402, Nigeria., Adebiyi O; University College Hospital, Ibadan, Oyo, 23402, Nigeria., Salako K; University College Hospital, Ibadan, Oyo, 23402, Nigeria., Baldeh I; National Public Health Laboratory Services, Banjul, The Gambia., Jallow A; National Public Health Laboratory Services, Banjul, The Gambia., Jallow M; National Public Health Laboratory Services, Banjul, The Gambia., Dagnra A; Laboratoire National de Reference Mycobacteria, Lome, Togo., Dissé K; Laboratoire National de Reference Mycobacteria, Lome, Togo., Kadanga EA; Laboratoire National de Reference Mycobacteria, Lome, Togo., Idigbe EO; Nigerian Institute of Medical Research, Lagos, Nigeria., Onubogu C; Nigerian Institute of Medical Research, Lagos, Nigeria., Onyejepu N; Nigerian Institute of Medical Research, Lagos, Nigeria., Gaye-Diallo A; Laboratoire Bactériologie Virologie Aristide Le Dantec Sénégal, Dakar, Senegal., Ba-Diallo A; Laboratoire Bactériologie Virologie Aristide Le Dantec Sénégal, Dakar, Senegal., Rabna P; National Institute of Public Health, Bissau, Guinea-Bissau., Mane M; National Institute of Public Health, Bissau, Guinea-Bissau., Sanogo M; SEREFO Program, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Diarra B; SEREFO Program, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali., Dezemon Z; Centre Muraz and the National TB Program, Ouagadougou, Burkina Faso., Sanou A; Centre Muraz and the National TB Program, Ouagadougou, Burkina Faso., Senghore M; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia.; Microbiology and Infection Unit, Warwick Medical School, University of Warwick, Coventry, UK., Kwambana-Adams BA; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia.; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK., Demba E; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia., Faal-Jawara T; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia., Kumar S; Institute of Tropical Medicine, Antwerp, Belgium., Tientcheu LD; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia.; Department of Biochemistry, Faculty of Science, University of Yaoundé 1, Yaoundé, Cameroon., Jallow A; National Tuberculosis/Leprosy Control Program, Banjul, The Gambia., Ceesay S; Health Services, Ministry of Health and Social Welfare, Banjul, The Gambia., Adetifa I; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.; Disease Control and Elimination, Medical Research Council Unit, Serrekunda, The Gambia., Jaye A; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia., Pallen MJ; Microbiology and Infection Unit, Warwick Medical School, University of Warwick, Coventry, UK., D'Alessandro U; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Disease Control and Elimination, Medical Research Council Unit, Serrekunda, The Gambia.; Institute of Tropical Medicine, Antwerp, Belgium., Kampmann B; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia.; Department of Paediatrics, Imperial College London, London, UK., Adegbola RA; GSK Vaccines, Wavre, Belgium., Mboup S; Laboratoire Bactériologie Virologie Aristide Le Dantec Sénégal, Dakar, Senegal., Corrah T; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia., de Jong BC; Institute of Tropical Medicine, Antwerp, Belgium., Antonio M; Vaccines and Immunity Theme, Medical Research Council Unit The Gambia, Banjul, The Gambia. mantonio@mrc.gm.; Microbiology and Infection Unit, Warwick Medical School, University of Warwick, Coventry, UK. mantonio@mrc.gm.; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. mantonio@mrc.gm.

Publikováno v: BMC medicine [BMC Med] 2016 Nov 03; Vol. 14 (1), pp. 160. Date of Electronic Publication: 2016 Nov 03.

Proficiency testing for HIV, tuberculosis and malaria diagnosis in clinical laboratories in Nigeria.

Autor: Audu RA; Human Virology Laboratory, Nigerian Institute of Medical Research, Nigeria., Onubogu CC; National Tuberculosis Reference Laboratory, Nigerian Institute of Medical Research, Nigeria., Okoye RN; Clinical Diagnostic Laboratory, Nigerian Institute of Medical Research, Nigeria., Nwokoye NN; National Tuberculosis Reference Laboratory, Nigerian Institute of Medical Research, Nigeria., Onwuamah CK; Human Virology Laboratory, Nigerian Institute of Medical Research, Nigeria., Musa AZ; Monitoring and Evaluation Unit, Nigerian Institute of Medical Research, Nigeria., Raheem TY; National Tuberculosis Reference Laboratory, Nigerian Institute of Medical Research, Nigeria., Aniedobe MN; Human Virology Laboratory, Nigerian Institute of Medical Research, Nigeria., Nduaga SJ; Clinical Diagnostic Laboratory, Nigerian Institute of Medical Research, Nigeria., Essien IO; Clinical Diagnostic Laboratory, Nigerian Institute of Medical Research, Nigeria., Idigbe EO; National Tuberculosis Reference Laboratory, Nigerian Institute of Medical Research, Nigeria.

Publikováno v: African journal of laboratory medicine [Afr J Lab Med] 2014 Oct 24; Vol. 3 (1), pp. 102. Date of Electronic Publication: 2014 Oct 24 (Print Publication: 2014).

Experience of quality management system in a clinical laboratory in Nigeria.

Autor: Audu RA; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Sylvester-Ikondu U; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Onwuamah CK; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Salu OB; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Ige FA; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Meshack E; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Aniedobe M; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Amoo OS; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Okwuraiwe AP; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Okhiku F; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Okoli CL; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Fasela EO; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Odewale EO; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Aleshinloye RO; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Olatunji M; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria., Idigbe EO; Human Virology Laboratory, Nigerian Institute of Medical Research, Lagos, Nigeria.

Publikováno v: African journal of laboratory medicine [Afr J Lab Med] 2012 Oct 29; Vol. 1 (1), pp. 18. Date of Electronic Publication: 2012 Oct 29 (Print Publication: 2012).